P. V. Murphy et al.
7.43 (m, 4H; Ar-H), 7.35 (t, 3J
(H,H)=7.8 Hz, 2H; Ar-H), 7.03 (d, 3J
3J(H,H)=1.4 Hz, 1H; H-4), 6.08 (dd, 3J
5.96 (dd, J
G
3.2 Hz, 1H; Ar-H), 5.12 (d, 2J
(H,H)=11.7 Hz, 1H; 1ꢂPhCHH), 4.62 (d, 2J
PhCHH), 4.47–4.38 (m, 2H; 1ꢂPhCHH and H-1), 4.34 (d, 2J
11.9 Hz, 1H; 1ꢂPhCHH), 4.12–4.04 (m, 2H; 1ꢂPhCHH and H-4), 3.92
ACHTUNGTRENNUNG
E
R
U
ACHTUNGTRENNUNG
A
R
ACHTUNGTRENNUNG
3
ACHTUNGTRENNUNG
3H; CH3); 13C (125 MHz, CDCl3): d=166.4, 165.5, 165.4, 165.1, 160.2
(each C=O), 133.7, 133.6, 133.4 (each CH), 130.0, 129.8, 129.7 (each CH),
128.8, 128.7 (each C), 128.6 (CH), 128.6(C), 128.4, 128.3 (each CH), 93.6
(C-1), 90.6 (C=NH), 71.2 (C-5), 69.4 (C-4), 67.8 (C-3), 67.3 (C-2),
52.9 ppm (CH3); HRMS calcd for C28H25O10 521.1448, found m/z (%)
521.1446 [M+H]+.
3
(t, J
3), 3.71 (m, 2H; H-6aꢄ and H-6b’), 3.67–3.50 (m, 3H; H-6a and H-6b and
H-2), 3.28 (s, 3H; CH3), 0.99 (s, 9H; C
(CH3)3); 13C NMR (125 MHz,
ACHTUNGTREN(NUGN H,H)=7.2 Hz, 1H; H-5’), 3.81 (m, 3H; 1ꢂPhCHH and H-5 and H-
AHCTUNGTRENNUNG
CDCl3): d=171.2, 165.6, 165.3, 165.1 (each C=O), 138.8, 138.4, 138.1
(each C), 135.5, 135.4 (each CH), 133.3, 133.0, 132.9 (each CH), 132.8,
132.4 (each C), 130.0, 129.9, 129.8, 129.7 (2s), (each CH), 129.6, 129.1
(each C), 128.6, 128.5, 128.2 (2s), 128.1, 127.8 (2s) 127.8, 127.7, 127.6 (2s),
127.5 (2s) (each CH), 101.6 (C-1’), 98.5 (C-1), 78.1 (C-3), 77.4 (C-2), 75.1
(C-4), 73.8 (PhCH2), 73.5 (PhCH2), 73.4 (PhCH2), 73.2 (C-5’), 72.2 (C-3’),
70.3 (C-2’), 69.7 (C-6), 69.1 (C-5), 67.6 (C-4’), 60.8 (C-6), 55.3 (OCH3),
Methyl 6-O-(2,3,4-tri-O-benzoyl-5-S-(methoxycarbonyl)-a-l-arabinopyra-
nosyl)-2,3,4-tri-O-benzoyl-a-d-galactopyranose (39): Regioselective gly-
cosidation of 38[34,35] (150 mg, 0.22 mmol) and 37 (100 mg, 0.22 mmol) as
described above gave the intermediate alcohol (165 mg, 77%) as a color-
less foam; 1H NMR (500 MHz, CDCl3): d=8.02–7.92 (m, 8H; Ar-H),
26.6 (CACHTUNRGTNNEU(G CH3)3), 18.9 ppm (CHCAUTNGTERN(NUNG CH3)3); ESI-HRMS calcd for C71H73O14Si
1177.4770, found m/z (%) 1177.4762 [M+H]+.
7.80 (d, 3J
H), 7.52–7.41 (m, 6H; Ar-H), 7.39–7.32 (m, 6H; Ar-H), 7.26 (dd, 3J-
(H,H)=9.1, 6.5 Hz, 2H; Ar-H), 6.17 (d, 3J
(H,H)=3.3 Hz, 1H; H-4’’),
5.78 (dd, 3J(H,H)=10.4, 7.9 Hz, 1H; H-2’), 5.69 (dd, 3J
(H,H)=10.7,
3.5 Hz, 1H; H-2), 5.62 (ddd, 3J
(H,H)=10.5, 7.3, 3.5 Hz, 2H; H-3 and H-
3’), 5.01 (d, 3J(H,H)=3.5 Hz, 1H; H-1), 4.97 (d, 3J
(H,H)=7.9 Hz, 1H;
H-1’), 4.61 (s, 1H; H-5’), 4.54 (s, 1H; H-4), 4.26 (dd, 2J
(H,H)=10.2 Hz,
3J(H,H)=6.4 Hz, 1H; H-6a), 4.18 (t, 3J
(H,H)=6.3 Hz, 1H; H-5), 4.00
(dd, 2J(H,H)=10.2 Hz, 3J
(H,H)=6.4 Hz, 1H; H-6b), 3.61 (s, 3H; CH3),
3.42
(d, 3J(H,H)=5.0 Hz, 1H; OH), 3.17 ppm (s, 3H; CH3); 13C NMR
ACHTUNGTRENNUNG ACHTUNGTERN(NUGN H,H)=7.5 Hz, 1H; Ar-
(H,H)=7.3 Hz, 2H; Ar-H), 7.56 (t, 3J
Methyl 4-O-(2,3,4-tri-O-benzoyl-5-S-(methoxycarbonyl)-a-l-arabinopyra-
nosyl)-2,3,6-tri-O-benzoyl-a-d-galactopyranoside (44): Acetic acid
(13 mL, 1 equiv) was added to a solution of 43 (263 mg, 0.22 mmol) in
THF (6 mL), and the mixture was cooled to 08C. After addition of
TBAF (1m in THF, 0.25 mL, 0.25 mmol), the mixture was stirred at 08C
for 2 h, then diluted with diethyl ether and washed with brine (ꢂ2). The
aqueous phase was reextracted with diethyl ether, and the combined or-
ganic phases were dried with Na2SO4, filtered, and the solvent was re-
moved under diminished pressure. Flash chromatography furnished the
R
ACHTUNGTRENNUNG
R
ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
G
ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
N
ACHTUNGTRENNUNG
A
ACHTUNGTRENNUNG
A
ACHTUNGTRENNUNG
desilylated intermediate (172 mg, 82%) as
(500 MHz, CDCl3): d=8.10 (d, 3J(H,H)=7.3 Hz, 2H; Ar-H), 7.93 (d, 3J-
(H,H)=7.4 Hz, 2H; Ar-H), 7.82 (d, J
3J(H,H)=7.4 Hz, 1H; Ar-H), 7.51 (t, 3J
7.33 (m, 7H; Ar-H), 7.33–7.20 (m, 10H; Ar-H), 7.17 (t, J
2H; Ar-H), 6.97 (dd, 3J(H,H)=6.5, 2.7 Hz, 2H; Ar-H), 5.84 (dd, 3J-
(H,H)=10.3, 8.0 Hz, 1H; H-2’), 5.79 (d, 3J
(H,H)=3.4 Hz, 1H; H-4’),
5.52 (dd, 3J(H,H)=10.3, 3.4 Hz, 1H; H-3’), 5.04 (d, 3J
(H,H)=8.0 Hz,
1H; H-1’), 4.70–4.59 (ABq, 2J
(H,H)=16.8, 11.7 Hz, 2H; PhCH2), 4.58–
4.49 (ABq, 2J(H,H)=15.9, 12.2 Hz, 2H; PhCH2), 4.44 (d, 3J
(H,H)=
3.6 Hz, 1H; H-1), 4.18 (d, J
(H,H)=2.4 Hz, 1H; H-4), 4.05 (dd, 2J
1H; H-6a), 3.95 (dd, 3J(H,H)=7.9, 5.2 Hz, 1H; H-5), 3.89 (d, 2J
11.8 Hz, 1H; 1ꢂPhCH2), 3.75 (m, 2H; H-5 and H-3), 3.72–3.65 (m, 1H;
H-6a’), 3.65–3.54 (m, 2H; H-6b and H-2), 3.45 (dd, 3J
(H,H)=10.6,
a
white foam; 1H NMR
(125 MHz, CDCl3): d=166.8, 166.1, 165.8, 165.6, 165.2, 165.1 (each C=
O), 133.6, 133.4 (ꢂ2), 133.2, 133.1 (each CH), 130.0, 129.8 (ꢂ2), 129.7
(each CH), 129.5, 129.2, 128.8, 128.7 (each C), 128.6, 128.4 (2s), 128.3
(each CH), 101.4 (C-1’’), 97.3 (C-1), 72.6 (C-5’), 71.3 (C-3’), 70.9 (C-2),
69.3 (C-3 and C-2’), 68.9 (C-4’), 68.7 (C-6), 68.5 (C-5), 67.3 (C-4), 55.1
(CH3), 52.9 ppm (CH3); ESI-HRMS calcd for C49H45O17 905.2657, found
m/z (%) 905.2655 [M+H]+. This intermediate (125 mg, 0.132 mmol) was
benzoylated using pyridine (4 mL) and benzoyl chloride (30 mL,
0.263 mmol) as described above to give 39 (118 mg, 90%) as a white
solid after chromatography (petroleum ether/EtOAc 2:1); 1H NMR
(500 MHz, CDCl3): d=8.11–8.05 (m, 2H; Ar-H), 8.05– 8.00(m, 2H; Ar-
H), 7.93 (m, 4H; Ar-H), 7.81–7.78 (m, 2H; Ar-H), 7.76–7.72 (m, 2H; Ar-
H), 7.60 (m, 2H; Ar-H), 7.53–7.30 (m, 12H; Ar-H), 7.29–7.17 (m, 4H;
Ar-H), 6.21–6.12 (m, 1H; H-4’), 5.90 (m, 2H; H-4, H-3), 5.83 (dd, 3J-
AHCTUNGTRENNUNG
3
A
ACHTUNGTRENNUNG
A
ACHTUNGTRENNUNG
3
AHCTUNGTREGUN(NN H,H)=7.8 Hz,
AHCTUNGTRENNUNG
A
ACHTUNGTRENNUNG
A
ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
A
ACHTUNGTRENNUNG
2
3
AHCTUNGTRENNUNG
A
R
ACHTUNGTRENNUNG
A
ACHTUNGTRENNUNG
E
ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
5.0 Hz, 1H; H-6b), 3.32–3.27 (m, 1H; OH), 3.26 (s, 3H; CH3); 13C NMR
(125 MHz, CDCl3): d=166.3, 165.6, 165.3 (each C=O), 138.7, 138.4, 137.8
(each C), 133.7, 133.3, 133.0 (each CH), 130.0 (2s), 129.8 (each CH),
129.5, 128.9, 128.8 (each C), 128.7, 128.6, 128.5, 128.3, 128.2, 128.1, 128.0,
127.9 (2 s), 127.8 (3s) (each CH), 102.3 (C-1’), 98.8 (C-1), 77.9 (C-3), 77.1
(C-2), 76.0 (C-4), 74.0 (C-5’), 73.7 (2ꢂPhCH2), 73.5 (PhCH2), 72.2 (C-3’),
70.1 (C-2’), 68.8 (C-4’), 68.3 (C-6), 67.6 (C-5), 61.0 (C-6’), 55.3 ppm
(CH3); ESI-HRMS calcd for C55H54NaO14 961.3411, found m/z (%)
961.3407 [M+Na]+. This intermediate (326 mg, 0.35 mmol) was added to
CH2Cl2 (10 mL) and H2O (5 mL) and treated with TEMPO (10 mg,
0.065 mmol) and BAIB (336 mg, 1.043 mmol) to give the acid. This was
esterified in DMF (10 mL) using NaHCO3 (220 mg, 2.6 mmol) and MeI
(0.055 mL, 0.87 mmol) to give the ester (290 mg, 87%) after chromatog-
A
ACHTUNGTRENNUNG
ACHTUNGTRENNUNG
G
ACHTUNGTRENNUNG
G
ACHTUNGTRENNUNG
CH3), 3.10 ppm (s, 3H; CH3); 13C NMR (125 MHz, CDCl3): d=166.3,
166.1, 165.5 (2s) 165.3, 165.2 (2s) (each C=O), 133. (2s), 133.3 (2s), 133.0
(each CH), 130.0, 129.9, 129.8 (2s), 129.7, 129.6 (each CH), 129.3, 129.2
(2s), 128.9, 128.7 (each C), 128.6 (2s), 128.4 (2s), 128.4, 128.3, 128.2 (each
CH), 101.9 (C-1’), 97.0 (C-1), 72.9 (C-5’), 71.2 (C-3’), 70.2 (C-6), 70.0 (C-
4), 69.4 (C-2), 69.2 (C-2’), 69.1 (C-4’), 68.4 (C-5), 68.9 (C-3), 55.0 (CH3),
52.8 ppm (CH3); ESI-HRMS calcd for C56H49O18 1009.2919, found m/z
(%) 1009.2924 [M+H]+.
Methyl 4-O-(6-O-tert-butyldiphenylsilyl-2,3,4-tri-O-benzoyl-b-d-galacto-
pyranosyl)-2,3,6-tri-O-benzyl-a-d-galactopyranose (43): Tf2O (0.080 mL,
0.48 mmol) was added to a stirred solution of the thioglycoside 41[36,37]
(370 mg, 0.44 mmol), benzene sulfonyl pyridine (92 mg, 0.44 mmol),
2,4,6-tri-tert-butylpyrimidine (220 mg, 0.89 mmol), and activated 3 ꢃ pow-
dered sieves in CH2Cl2 (5 mL), at ꢀ608C, under argon. After 5 min, a so-
lution of the glycosyl acceptor 42 (286 mg, 0.60 mmol) in dichlorome-
thane (4 mL) was added. The mixture was allowed to attain room tem-
perature, filtered, washed with satd. aq. NaHCO3, brine, dried (Na2SO4),
and the solvent was then removed under diminished pressure. Chroma-
tography of the residue (petroleum ether/EtOAc, 3:1) gave the title com-
raphy (petroleum ether/EtOAc 2:1) as
(500 MHz, CDCl3): d=8.02 (dd, 3J
(H,H)=8.2, 1.1 Hz, 2H; Ar-H), 7.96
(dd, 3J(H,H)=8.3, 1.1 Hz, 2H; Ar-H), 7.83 (dd, 3J
(H,H)=8.3, 1.2 Hz,
2H; Ar-H), 7.63–7.57 (m, 1H; Ar-H), 7.51–7.16 (m, 21H; Ar-H), 7.01
(dd, 3J(H,H)=6.8, 2.6 Hz, 2H; Ar-H), 6.14 (dd, 3J
(H,H)=3.4, 1.1 Hz,
1H; H-4’), 5.80 (dd, 3J(H,H)=10.4, 7.9 Hz, 1H; H-2’), 5.53 (dd, 3J-
(H,H)=10.4, 3.4 Hz, 1H; H-3’), 5.18 (d, 3J
(H,H)=7.9 Hz, 1H; H-1’),
4.71 (dd, 2J(H,H)=11.8, 8.0 Hz, 2H; PhCH2), 4.64 (dd, 2J
(H,H)=11.8,
4.3 Hz, 2H; PhCH2), 4.50 (d, 3J(H,H)=3.6 Hz, 1H; H-1), 4.43 (d, 3J-
(H,H)=1.2 Hz, 1H; H-5’), 4.26 (d, 3J
(H,H)=2.4 Hz, 1H; H-4), 4.15 (d,
2J(H,H)=11.7 Hz, 1H; PhCHH), 4.01 (dd, 2J(H,H)=9.9 Hz, 3J
(H,H)=
6.0 Hz, 1H; H-6a), 3.96 (t, J
11.7 Hz, 1H; PhCHH), 3.86 (dd, 3J
(dd, 2J(H,H)=9.9 Hz, 3J
a
white foam; 1H NMR
AHCTUNGTRENNUNG
A
ACHTUNGTRENNUNG
A
ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
A
ACHTUNGTRENNUNG
A
ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
A
ACHTUNGTRENNUNG
1
A
E
ACHTUNGTRENNUNG
pound 43 (466 mg, 90%) as a white foam; H NMR (500 Hz, CDCl3): d=
3
2
8.04 (d, J=7.4 Hz, 2H; Ar-H), 7.91 (d, J=7.5 Hz, 2H; Ar-H), 7.82 (d,
E
ACHTUNGTRENNUNG(H,H)=
J=7.4 Hz, 2H; Ar-H), 7.64 (dd, 3J
(H,H)=13.1, 7.0 Hz, 3H; Ar-H), 7.49
ACHTUNGTRENNUNG
3
(t, J
G
A
ACHTUNGTRENUN(NG H,H)=6.0 Hz, 1H; H-6b), 3.65–3.59 (m, 4H;
15H; Ar-H), 6.95 (d, 3J
N
G
CH3 and H-2), 3.32 ppm (s, 3H; CH3); 13C NMR (125 MHz, CDCl3): d=
166.2, 165.6, 165.2, 165.1 (each C=O), 138.8 (2s), 138.4 (each C), 133.5,
AHCTUNGTRENNUNG
14848
ꢁ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2013, 19, 14836 – 14851